| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139;
Forsyth Institute, Boston, Massachusetts 02115
Helicobacter bilis and H. hepaticus, both urease-positive intestinal helicobacters of mice, have been shown experimentally to induce proliferative typhlocolitis in scid mice. We recently isolated a urease-negative Helicobacter sp. (H. sp.) that also induced proliferative typhlocolitis in pilot studies in scid mice. To determine the pathogenic potential of H. sp. in immunocompromised and immunocompetent mice, 5-week old male A/J or Tac:Icr:Ha(ICR)-scidfRF mice were inoculated by intraperitoneal (IP) injection with 
3 x 107 colony-forming units (CFU) of H. sp. Mice were necropsied at various time points postinoculation (PI). Sham-inoculated mice had no clinical, gross, or histopathological lesions. In contrast, scid mice inoculated IP with H. sp. had severe hemorrhagic diarrhea and decreased weight gain at 2, 7, and 18 weeks postinoculation (PI), with severe proliferative typhlocolitis, phlebothrombosis, and hepatitis. A/J mice had no clinical signs, but had mild to moderate proliferative typhlocolitis and moderate to marked cholangiohepatitis at 7 and 24 weeks PI. A/J mice infected with H. sp. developed robust immune responses of a predominant Th1 type. This report demonstrates that infection with a urease-negative helicobacter can cause inflammatory bowel disease (IBD) and hepatitis in scid and immunocompetent A/J mice. These results provide a new model of IBD and cholangiohepatitis associated with a specific urease-negative, novel H. species.
Key Words: Helicobacter • mouse • typhlocolitis • cholangiohepatitis
This article has been cited by other articles:
|
|
 |
|
  N. S. Taylor, S. Xu, P. Nambiar, F. E. Dewhirst, and J. G. Fox Enterohepatic Helicobacter Species Are Prevalent in Mice from Commercial and Academic Institutions in Asia, Europe, and North America J. Clin. Microbiol., July 1, 2007; 45(7): 2166 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. R. M. Bohr, M. Selgrad, C. Ochmann, S. Backert, W. Konig, A. Fenske, T. Wex, and P. Malfertheiner Prevalence and spread of enterohepatic helicobacter species in mice reared in a specific-pathogen-free animal facility. J. Clin. Microbiol., March 1, 2006; 44(3): 738 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Nambiar, S. M. Kirchain, K. Courmier, S. Xu, N. S. Taylor, E. J. Theve, M. M. Patterson, and J. G. Fox Progressive Proliferative and Dysplastic Typhlocolitis in Aging Syrian Hamsters Naturally Infected with Helicobacter spp.: A Spontaneous Model of Inflammatory Bowel Disease Vet. Pathol., January 1, 2006; 43(1): 2 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Shomer, J. G. Fox, A. E. Juedes, and N. H. Ruddle Helicobacter-Induced Chronic Active Lymphoid Aggregates Have Characteristics of Tertiary Lymphoid Tissue Infect. Immun., June 1, 2003; 71(6): 3572 - 3577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Ananieva, I. Nilsson, T. Vorobjova, R. Uibo, and T. Wadstrom Immune Responses to Bile-Tolerant Helicobacter Species in Patients with Chronic Liver Diseases, a Randomized Population Group, and Healthy Blood Donors Clin. Vaccine Immunol., November 1, 2002; 9(6): 1160 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.S. Nichols Love in the Time of Helicobacter Experimental Biology and Medicine, July 1, 2002; 227(7): 435iii. [Full Text] [PDF]
|
|
|
|
|
|
S. Feng, E. Hodzic, L. V. Kendall, A. Smith, K. Freet, and S. W. Barthold Cloning and Expression of a Helicobacter bilis Immunoreactive Protein Clin. Vaccine Immunol., May 1, 2002; 9(3): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Garcia, S. E. Erdman, S. Xu, Y. Feng, A. B. Rogers, M. D. Schrenzel, J. C. Murphy, and J. G. Fox Hepatobiliary Inflammation, Neoplasia, and Argyrophilic Bacteria in a Ferret Colony Vet. Pathol., March 1, 2002; 39(2): 173 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J G Fox The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases Gut, February 1, 2002; 50(2): 273 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Franklin, P. L. Gorelick, L. K. Riley, F. E. Dewhirst, R. S. Livingston, J. M. Ward, C. S. Beckwith, and J. G. Fox Helicobacter typhlonius sp. nov., a Novel Murine Urease-Negative Helicobacter Species J. Clin. Microbiol., November 1, 2001; 39(11): 3920 - 3926. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
